Arkolith/Insider Trading/LJPC/Form 4

Tang Kevin C

Director, 10% OwnerLA JOLLA PHARMACEUTICAL CO (LJPC) · full profile →Form 4 · filed Aug 24, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2022Tender(U)9.6M$6.23$59.9M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 22, 2022Disposed to issuer(D)12K——0
Aug 22, 2022Disposed to issuer(D)12K——0
Aug 22, 2022Disposed to issuer(D)30K——0
Aug 22, 2022Disposed to issuer(D)30K—$00
Aug 22, 2022Disposed to issuer(D)10K——0
Aug 22, 2022Disposed to issuer(D)18K——0
Aug 22, 2022Disposed to issuer(D)10K——0
Aug 22, 2022Disposed to issuer(D)10K——0
Aug 22, 2022Disposed to issuer(D)10K——0
Aug 22, 2022Tender(U)4K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-029660) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML